Featured Research

from universities, journals, and other organizations

Researcher Finding Ways To Make Cochlear Implants Better Mimic Normal Hearing

Date:
March 2, 1999
Source:
University Of Iowa
Summary:
Using a computer model, Jay Rubinstein, M.D, Ph.D., a University of Iowa assistant professor of otolaryngology, and physiology and biophysics, has found a way to better mimic the natural spontaneous activity of the normal cochlea, which could lead to improved hearing for people who rely on cochlear implants.

IOWA CITY, Iowa -- Although cochlear implants have opened up the world of sound for many individuals with profound hearing loss or deafness, the devices fall short of replicating the normal hearing process.

But that could soon change.

Using a computer model, Jay Rubinstein, M.D, Ph.D., a University of Iowa assistant professor of otolaryngology, and physiology and biophysics, has found a way to better mimic the natural spontaneous activity of the normal cochlea, which could lead to improved hearing for people who rely on cochlear implants.

Rubinstein, who figured out how to reprogram existing devices, soon will begin trials on qualified UI Hospitals and Clinics' patients already implanted with cochlear devices. An initial test of a reprogrammed implant in a North Carolina patient provided promising data, Rubinstein said. The UI Research Foundation has applied for a patent for Rubinstein's strategy.

"While much work remains to be done in humans, our laboratory studies suggest that substantial improvements in all types of sound coding may be possible, even with the limitations of currently implanted devices," Rubinstein said.

In normal hearing, sound waves excite the hair cells in the ear. These cells then convert the sound into an electrical signal that stimulates the primary auditory neurons to send the information from the inner ear's cochlea to the auditory brain stem. The hearing process is impaired in people who have lost some hair cells. Those with no hair cells at all are deaf because the hearing process cannot even start.

A cochlear implant is an electronic device that a doctor surgically places in a deaf person's cochlea. The device, which receives signals from a processor worn outside the body, acts as the hair cells, converting acoustic information into electrical signals that can be transmitted to the brain and perceived as sound.

Although the cochlear implant is supposed to mimic the normal hearing process, the electrically stimulated auditory neuron responses are substantially different from acoustically stimulated responses in the normal hearing ear. The device's electrical stimulation produces highly synchronized activity across all the neurons, meaning the response is the same for all the neurons. Acoustic stimulation produces much less across-neuron synchrony, meaning each neuron's response is independent. This independence allows for much richer, more detailed sound.

Rubinstein wanted to find a way to recreate the desynchronized, natural process of normal acoustic stimulation. By increasing the rate of the signal pulses from the external processor, Rubinstein, in his model, was able to produce more independent neuron activity. Animal studies performed at the UI support the predictions of Rubinstein's calculations. Individuals involved in the animal studies included Paul Abbas, Ph.D. professor of otolaryngology, and speech pathology and audiology; Charles Miller, Ph.D., assistant research scientist in the Department of Otolaryngology; and Akihiro Matsuoka , M.D., Ph.D., research assistant in the Department of Otolaryngology.

Earlier work performed by Blake Wilson at the Research Triangle Institute in North Carolina, a close collaborator with the UI Cochlear Implant Clinical Research Center, suggested that coding speech at high signal rates would reduce neural synchronization.

"Our work demonstrated precisely how those beneficial effects could be exploited to partially mimic the function of the normal auditory system," Rubinstein said.

If upcoming human trials are successful, a limited version of the new speech processing strategy is possible using currently implanted devices. These improved versions could be available to UI research subjects within months, Rubinstein said. U.S. Food and Drug Administration approval would be necessary prior to more widespread use. A complete implementation of the algorithm is beyond the capabilities of even the most sophisticated cochlear implants available today but will be possible using devices that the manufacturers will make available in the next few years, Rubinstein said.


Story Source:

The above story is based on materials provided by University Of Iowa. Note: Materials may be edited for content and length.


Cite This Page:

University Of Iowa. "Researcher Finding Ways To Make Cochlear Implants Better Mimic Normal Hearing." ScienceDaily. ScienceDaily, 2 March 1999. <www.sciencedaily.com/releases/1999/03/990302063056.htm>.
University Of Iowa. (1999, March 2). Researcher Finding Ways To Make Cochlear Implants Better Mimic Normal Hearing. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/03/990302063056.htm
University Of Iowa. "Researcher Finding Ways To Make Cochlear Implants Better Mimic Normal Hearing." ScienceDaily. www.sciencedaily.com/releases/1999/03/990302063056.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins